Genric name (abbreviation) | 6-thioguanine (6TG) | |
---|---|---|
ATC-code | ATC-code L0JBB03 | |
Name and formulation | Oral suspension, 5 mg/ml | |
Adverse Reactions (frequency) | Very common (> 1/10) | Bone marrow failure, sinusoidal obstruction syndrome (SOS), hyperbilirubinemia, hepatomegaly, weight increase due to fluid retention and ascites, portal hypertension, splenomegaly, esophageal varices and thrombocytopenia, increased hepatic enzymes, increased blood alkaline phosphatase and gamma glutamyl transferase, jaundice, portal fibrosis, nodular regenerative hyperplasia, peliosis hepatis |
Common (> 1/100 to < 1/10) | Stomatitis, gastrointestinal disorder, SOS in short-term cyclical therapy, hyperuricemia, hyperuricosuria and urate nephopathy | |
Uncommon (≥1/1000 to < 1/100) | ||
Rare (≥1/10,000 to < 1/1000) | Necrotising colitis, hepatic necrosis | |
Very rare (< 1/10,000) | ||
Unknown | Photosensitivity |